Evidence map›Paper›PMID 39550374›Full record

ArticleNature communications2024

Autoinflammatory patients with Golgi-trapped CDC42 exhibit intracellular trafficking defects leading to STING hyperactivation and ER stress.

Alberto Iannuzzo, Selket Delafontaine, Rana El Masri, Rachida Tacine, Giusi Prencipe, Masahiko Nishitani-Isa, Rogier T A van Wijck, Farzana Bhuyan, Adriana A de Jesus Rasheed, Simona Coppola and 7 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Therapeutic targeting of the cGAS-STING pathway in human disease.The Journal of clinical investigation · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Alberto IannuzzoUniversité Paris Cité, CNRS, Inserm, Institut Cochin, F-75014, Paris, France.ORCID 0000-0001-8053-2362
Selket DelafontaineLaboratory for Inborn Errors of Immunity, KU Leuven, Leuven, Belgium.ORCID 0000-0002-8985-8155
Rana El MasriUniversité Paris Cité, CNRS, Inserm, Institut Cochin, F-75014, Paris, France.
Rachida TacineUniversité Paris Cité, CNRS, Inserm, Institut Cochin, F-75014, Paris, France.
Giusi PrencipeLaboratory of Immuno-Rheumatology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Masahiko Nishitani-IsaDepartment of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan.ORCID 0000-0001-7816-9517
Rogier T A van WijckDepartment of Pathology & Clinical Bioinformatics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Farzana BhuyanTranslational Autoinflammatory Disease Section (TADS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, MD, 20892, USA.
Adriana A de Jesus RasheedTranslational Autoinflammatory Disease Section (TADS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, MD, 20892, USA.ORCID 0000-0001-8966-8362
Simona CoppolaNational Center for Rare Diseases, Istituto Superiore di Sanità, 00161, Rome, Italy.ORCID 0000-0001-7851-9409
Paul L A van DaeleDepartment of Internal Medicine, Division of Allergy & Clinical Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Antonella InsalacoDivision of Rheumatology, ERN RITA Center, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy.
Raphaela Goldbach-ManskyTranslational Autoinflammatory Disease Section (TADS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, MD, 20892, USA.ORCID 0000-0001-7865-5769
Takahiro YasumiDepartment of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan.ORCID 0000-0003-3257-5071
Marco TartagliaMolecular Genetics and Functional Genomics, Bambino Gesù Children's Hospital, IRCCS, 00146, Rome, Italy.ORCID 0000-0001-7736-9672
Isabelle MeytsLaboratory for Inborn Errors of Immunity, KU Leuven, Leuven, Belgium.
Jérôme DelonUniversité Paris Cité, CNRS, Inserm, Institut Cochin, F-75014, Paris, France. jerome.delon@inserm.fr.ORCID 0000-0003-0222-1192

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most autoinflammatory diseases are caused by mutations in innate immunity genes. Previously, four variants in the RHO GTPase CDC42 were discovered in patients affected by syndromes generally characterized by neonatal-onset of cytopenia and auto-inflammation, including hemophagocytic lymphohistiocytosis and rash in the most severe form (NOCARH syndrome). However, the mechanisms responsible for these phenotypes remain largely elusive. Here, we show that the recurrent p.R186C CDC42 variant, which is trapped in the Golgi apparatus, elicits a block in both anterograde and retrograde transports. Consequently, it favours STING accumulation in the Golgi in a COPI-dependent manner. This is also observed for the other Golgi-trapped p.*192 C*24 CDC42 variant, but not for the p.Y64C and p.C188Y variants that do not accumulate in the Golgi. We demonstrate that the two Golgi-trapped CDC42 variants are the only ones that exhibit overactivation of the STING pathway and the type I interferon response, and elicit endoplasmic reticulum stress. Consistent with these results, patients carrying Golgi-trapped CDC42 mutants present very high levels of circulating IFNα at the onset of their disease. In conclusion, we report further mechanistic insights on the impact of the Golgi-trapped CDC42 variants. This increase in STING activation provides a rationale for combination treatments for these severe cases.

Indexed as

cdc42 GTP-Binding ProteinEndoplasmic Reticulum StressGolgi ApparatusMembrane ProteinsProtein TransportFemaleHEK293 CellsHumansInflammationMaleMutationSTING Proteincdc42 GTP-Binding ProteinCDC42 protein, humanMembrane ProteinsSTING1 protein, humanSTING Protein

Identifiers

PMID39550374
PMCPMC11569173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.